Test Bank:
yi
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
yi yi yi yi yi yi yi yi yi
Edition, 2024
yi
, Table of Contents yi yi
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
yi yi yi yi yi yi yi yi
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ................................................................... 13
yi yi yi yi
Chapter4: Pharmacogenetics and Pharmacogenomics................................................................................ 25
yi yi yi
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
yi yi yi yi yi yi
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
yi yi yi yi yi yi
Chapter 7: Drug Development and Approval ............................................................................................ 45
yi yi yi yi yi
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
yi yi yi yi yi yi yi yi yi
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
yi yi yi yi yi
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
yi yi yi yi yi
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
yi yi yi yi yi yi yi yi yi
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
yi yi yi yi yi yi yi yi yi yi yi y
14: Pharmacotherapy for Eye Conditions ................................................................................................... 67
i yi yi yi yi
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
yi yi yi yi yi
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
yi yi yi yi yi
Chapter 17: Pharmacotherapy for Cardiovascular Conditions.................................................................. 94
yi yi yi yi yi
Chapter 18: Pharmacotherapy for Respiratory Conditions ..................................................................... 106
yi yi yi yi yi
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
yi yi yi yi yi yi yi yi yi
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
yi yi yi yi yi
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
yi yi yi yi yi yi yi yi yi
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
yi yi yi yi yi yi yi
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
yi yi yi yi yi yi yi
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
yi yi yi yi yi
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
yi yi yi yi yi
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist .................................. 190
yi yi yi yi yi yi yi yi
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................ 196
yi yi yi yi yi yi yi
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
yi yi yi yi yi yi yi
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
yi yi yi yi yi yi
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
yi yi yi
Chapter 31: Antiretroviral Pharmacotherapy............................................................................................ 235
yi yi yi
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
yi yi yi yi yi yi yi yi yi yi
ognitive Conditions .................................................................................................................................... 247
yi
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
yi yi yi yi yi
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ...................................... 267
yi yi yi yi yi yi yi yi yi
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
yi yi yi
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
yi yi yi yi
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
yi yi yi yi yi yi yi yi
MULTIPLE CHOICE yi
• What is the primary purpose of the nursing assessment?
yi yi yi yi yi yi yi yi
A. Identifying underlying pathologic conditions yi yi yi
B. Assisting the physician in identifying medical conditions yi yi yi yi yi yi
C. Determining the patients mental status yi yi yi yi
D. Exploring patient responses to health problems yi yi yi yi yi
ANS: D yi
A nursing assessment is done to identify the patients response to health pr
yi yi yi yi yi yi yi yi yi yi yi yi
oblems. During the nursing assessment phase, a comprehensive informatio
yi yi yi yi yi yi yi yi
n base is developed through a physical examination, nursing history, medi
yi yi yi yi yi yi yi yi yi yi
cation history, and professional observation. Identifying underlying pathol
yi yi yi yi yi yi yi
ogic conditions and assisting the physician in identifying medical conditio
yi yi yi yi yi yi yi yi yi
ns is not part of the nursing process. Determining the patients mental stat
yi yi yi yi yi yi yi yi yi yi yi yi
us is one part of the nursing assessment, but it is not the primary purp
yi yi yi yi yi yi yi yi yi yi yi yi yi yi
ose.
DIF: Cognitive Level: Comprehension
yi yi yi y
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
i yi yi yi yi yi yi yi yi yi
Process Step: Assessment yi yi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
yi yi yi yi yi yi yi yi
• What is the basis of the NANDA I taxonomy?
yi yi yi yi yi yi yi y i
A. Functional health patterns yi yi
B. Human response patterns yi yi
C. Basic human needs yi yi
D. Pathophysiologic needs yi
ANS: B yi
The NANDA I taxonomy identifies human response patterns. Func
y i y i y i y i y i y i y i yi
tional components of health patterns are limited to activity, fluid volume,
yi yi yi yi yi yi yi yi yi yi
nutrition, self care, and sensory perception. Basic human needs comprise
yi yi yi yi yi yi yi yi yi yi
less than merely health patterns. Pathophysiologic needs are not part o
yi yi yi yi yi yi yi yi y i yi yi
f the scope of NANDA I.
yi yi yi yi yi
, DIF: Cognitive Level: Knowledge RE
yi yi yi yi
F: pp. 37-38 OBJ: 5 TOP:
yi yi yi yi yi
Nursing Process Step: Diagnosis yi yi yi
MSC: NCLEX Client Needs Category: Physiological Integrity
yi yi yi yi yi yi
• Which task is included in the assessment step of the nursing process?
yi yi yi yi yi yi yi yi yi yi yi
A. Establishing patient goals/outcomes yi yi
B. Implementing the nursing care plan (NCP) yi yi yi yi yi
C. Measuring goal/outcome achievement yi yi
D. Collecting and communicating data yi yi yi
ANS: D yi
Data are collected and communicated in the assessment phase of the nursi
yi yi yi yi yi yi yi yi yi yi yi
ng process. Establishing goals is the function of planning.
yi yi yi yi yi yi yi yi
Implementing the NCP is the function of implementation. Measuring outc
yi yi yi yi yi yi yi yi yi
ome achievement is the function of evaluation.
yi yi yi yi yi yi
DIF: Cognitive Level: Comprehension
yi yi yi y
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
i yi yi yi yi yi yi yi yi yi
Process Step: Assessment yi yi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
yi yi yi yi yi yi yi yi
• Which statement regarding nursing diagnoses is accurate?
yi yi yi yi yi yi
a. Nursing diagnoses remain the same for as long as the disease is present.
yi yi yi yi yi yi yi yi yi yi yi yi
b. Nursing diagnoses are written to identify disease states.
yi yi yi yi yi yi yi
c. Nursing diagnoses describe patient problems that nurses treat.
yi yi yi yi yi yi yi
d. Nursing diagnoses identify causes related to illness.yi yi yi yi yi yi
ANS: C yi
Diagnostic statements identify problems a nurse is independently able to t
yi yi yi yi yi yi yi yi yi yi
reat within the scope of professional practice. Nursing diagnoses vary wit
yi yi yi yi yi yi yi yi yi yi
h the changing condition of the patient. The response patterns are unique
yi yi yi yi yi yi yi yi yi yi yi yi
to the patient and are not disease specific. Nursing diagnoses describe the
yi yi yi yi yi yi yi yi yi yi yi y
patients human response pattern.
i yi yi yi
DIF: Cognitive Level: Comprehension
yi yi yi
yi
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
yi yi yi yi yi yi yi yi yi
Edition, 2024
yi
, Table of Contents yi yi
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
yi yi yi yi yi yi yi yi
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ................................................................... 13
yi yi yi yi
Chapter4: Pharmacogenetics and Pharmacogenomics................................................................................ 25
yi yi yi
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
yi yi yi yi yi yi
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
yi yi yi yi yi yi
Chapter 7: Drug Development and Approval ............................................................................................ 45
yi yi yi yi yi
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
yi yi yi yi yi yi yi yi yi
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
yi yi yi yi yi
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
yi yi yi yi yi
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
yi yi yi yi yi yi yi yi yi
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
yi yi yi yi yi yi yi yi yi yi yi y
14: Pharmacotherapy for Eye Conditions ................................................................................................... 67
i yi yi yi yi
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
yi yi yi yi yi
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
yi yi yi yi yi
Chapter 17: Pharmacotherapy for Cardiovascular Conditions.................................................................. 94
yi yi yi yi yi
Chapter 18: Pharmacotherapy for Respiratory Conditions ..................................................................... 106
yi yi yi yi yi
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
yi yi yi yi yi yi yi yi yi
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
yi yi yi yi yi
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
yi yi yi yi yi yi yi yi yi
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
yi yi yi yi yi yi yi
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
yi yi yi yi yi yi yi
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
yi yi yi yi yi
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
yi yi yi yi yi
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist .................................. 190
yi yi yi yi yi yi yi yi
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................ 196
yi yi yi yi yi yi yi
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
yi yi yi yi yi yi yi
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
yi yi yi yi yi yi
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
yi yi yi
Chapter 31: Antiretroviral Pharmacotherapy............................................................................................ 235
yi yi yi
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
yi yi yi yi yi yi yi yi yi yi
ognitive Conditions .................................................................................................................................... 247
yi
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
yi yi yi yi yi
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ...................................... 267
yi yi yi yi yi yi yi yi yi
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
yi yi yi
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
yi yi yi yi
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
yi yi yi yi yi yi yi yi
MULTIPLE CHOICE yi
• What is the primary purpose of the nursing assessment?
yi yi yi yi yi yi yi yi
A. Identifying underlying pathologic conditions yi yi yi
B. Assisting the physician in identifying medical conditions yi yi yi yi yi yi
C. Determining the patients mental status yi yi yi yi
D. Exploring patient responses to health problems yi yi yi yi yi
ANS: D yi
A nursing assessment is done to identify the patients response to health pr
yi yi yi yi yi yi yi yi yi yi yi yi
oblems. During the nursing assessment phase, a comprehensive informatio
yi yi yi yi yi yi yi yi
n base is developed through a physical examination, nursing history, medi
yi yi yi yi yi yi yi yi yi yi
cation history, and professional observation. Identifying underlying pathol
yi yi yi yi yi yi yi
ogic conditions and assisting the physician in identifying medical conditio
yi yi yi yi yi yi yi yi yi
ns is not part of the nursing process. Determining the patients mental stat
yi yi yi yi yi yi yi yi yi yi yi yi
us is one part of the nursing assessment, but it is not the primary purp
yi yi yi yi yi yi yi yi yi yi yi yi yi yi
ose.
DIF: Cognitive Level: Comprehension
yi yi yi y
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
i yi yi yi yi yi yi yi yi yi
Process Step: Assessment yi yi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
yi yi yi yi yi yi yi yi
• What is the basis of the NANDA I taxonomy?
yi yi yi yi yi yi yi y i
A. Functional health patterns yi yi
B. Human response patterns yi yi
C. Basic human needs yi yi
D. Pathophysiologic needs yi
ANS: B yi
The NANDA I taxonomy identifies human response patterns. Func
y i y i y i y i y i y i y i yi
tional components of health patterns are limited to activity, fluid volume,
yi yi yi yi yi yi yi yi yi yi
nutrition, self care, and sensory perception. Basic human needs comprise
yi yi yi yi yi yi yi yi yi yi
less than merely health patterns. Pathophysiologic needs are not part o
yi yi yi yi yi yi yi yi y i yi yi
f the scope of NANDA I.
yi yi yi yi yi
, DIF: Cognitive Level: Knowledge RE
yi yi yi yi
F: pp. 37-38 OBJ: 5 TOP:
yi yi yi yi yi
Nursing Process Step: Diagnosis yi yi yi
MSC: NCLEX Client Needs Category: Physiological Integrity
yi yi yi yi yi yi
• Which task is included in the assessment step of the nursing process?
yi yi yi yi yi yi yi yi yi yi yi
A. Establishing patient goals/outcomes yi yi
B. Implementing the nursing care plan (NCP) yi yi yi yi yi
C. Measuring goal/outcome achievement yi yi
D. Collecting and communicating data yi yi yi
ANS: D yi
Data are collected and communicated in the assessment phase of the nursi
yi yi yi yi yi yi yi yi yi yi yi
ng process. Establishing goals is the function of planning.
yi yi yi yi yi yi yi yi
Implementing the NCP is the function of implementation. Measuring outc
yi yi yi yi yi yi yi yi yi
ome achievement is the function of evaluation.
yi yi yi yi yi yi
DIF: Cognitive Level: Comprehension
yi yi yi y
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
i yi yi yi yi yi yi yi yi yi
Process Step: Assessment yi yi
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
yi yi yi yi yi yi yi yi
• Which statement regarding nursing diagnoses is accurate?
yi yi yi yi yi yi
a. Nursing diagnoses remain the same for as long as the disease is present.
yi yi yi yi yi yi yi yi yi yi yi yi
b. Nursing diagnoses are written to identify disease states.
yi yi yi yi yi yi yi
c. Nursing diagnoses describe patient problems that nurses treat.
yi yi yi yi yi yi yi
d. Nursing diagnoses identify causes related to illness.yi yi yi yi yi yi
ANS: C yi
Diagnostic statements identify problems a nurse is independently able to t
yi yi yi yi yi yi yi yi yi yi
reat within the scope of professional practice. Nursing diagnoses vary wit
yi yi yi yi yi yi yi yi yi yi
h the changing condition of the patient. The response patterns are unique
yi yi yi yi yi yi yi yi yi yi yi yi
to the patient and are not disease specific. Nursing diagnoses describe the
yi yi yi yi yi yi yi yi yi yi yi y
patients human response pattern.
i yi yi yi
DIF: Cognitive Level: Comprehension
yi yi yi
